The purpose of this review is to highlight important recent imaging, histological, and genetic findings relevant to white matter abnormalities in schizophrenia. It is cast within the context of research findings conducted over the last 5 years, where we analyze their importance in understanding schizophrenia, as well as discuss future directions for research.
Introduction
Research findings in schizophrenia largely confirm structural brain abnormalities, which are present in a large number of brain regions, some of which are disparate in terms of proximity, but are nonetheless highly functionally related (see review in [1] ). The notion, however, that schizophrenia is a disorder characterized by abnormal frontal and temporal connections has its historical roots in the beginning of the last century, when Wernicke [2] and Kraepelin [3] suggested the importance of frontotemporal connections in the neuropathology of schizophrenia. This hypothesis reemerged more recently, with new brain investigations involving various imaging methods [4] [5] [6] [7] [8] .
These studies and others have led to magnetic resonance imaging (MRI) structural findings of gray matter abnormalities in schizophrenia, although there has been no compelling postmortem evidence to suggest a concomitant neuronal loss in these brain regions. Instead, abnormalities of neuronal cytoarchitecture have been found in microscopic postmortem investigations in schizophrenia. These abnormalities include a reduction in neuronal size, dendritic spine density, dendritic length, and in synaptic proteins (for a review, see Harrison [9] ). Moreover, neuropathological studies suggest that astrocytes and oligodendrocytes, glial cells involved in signal conduction and cell metabolism [10] , may be abnormal in schizophrenia [11] . Since glial cells also play an important role in neuronal migration and in synaptic function (including glutamatergic and N-methyl-D-aspartate regulation), their dysfunction could lead to abnormalities observed in schizophrenia, such as reduced neuronal size, reduced levels of synaptic proteins, as well as abnormalities in neurotransmission and functional disconnectivity. Of further note, genetic studies [12] also point to oligodendrocyte abnormalities in schizophrenia.
Recently, in-vivo magnetic resonance methods have been introduced which are sensitive to white matter organization and may be useful in investigating abnormalities in schizophrenia. Specifically, diffusion tensor imaging (DTI), an indicator of the coherence, organization and density of the fibers within the white matter fiber bundles, has been applied to several investigations of schizophrenia, in which both disseminated as well as focal white matter abnormalities have been reported (for a review, see [13, 14 ] ). Magnetization transfer imaging, another new MRI technique believed to be sensitive to axonal and myelin integrity [15] , has been used to investigate white matter lesions in multiple sclerosis, increasing both the sensitivity and specificity of white matter MRI findings. This technique has also been applied to schizophrenia to describe white matter abnormalities [16, 17] .
Structural MRI studies, which have thus far shown mainly negative findings for white matter (see review in [1]), have benefited from new advances in both imaging and image processing analyses. Voxel-based morphometry (VBM), a technique that affords an opportunity to test for magnetic resonance intensity differences between groups of individuals in multiple regions of the brain without a priori hypothesis [18] , has also been applied to the study of white matter in schizophrenia. This technique has been shown to be more sensitive to white matter structural abnormalities than traditional investigations based on structural MRI measurements of white matter volume [19, 20] .
What these new tools have in common is that they provide converging evidence for white matter pathology in schizophrenia. Since white matter pathology is not easily discerned (i.e. MRI clinical readings of schizophrenia scans are mostly negative, there are no reports of gliosis in the brains of patients diagnosed with schizophrenia, and neuronal loss, if any, is also questionable), the combination of multiple techniques, along with a better understanding of both their advantages as well as their limitations, is necessary to understand further the neuropathology behind this devastating disease. Below, we review the most recent white matter abnormality findings in schizophrenia, published between 1 January 2003 and August 2004. Studies have been selected using PubMed and Medline, using the key words white matter and schizophrenia.
Structural white matter abnormalities in schizophrenia
As mentioned previously, magnetic resonance structural imaging studies of white matter in schizophrenia have thus far not been very informative. Only a small number of MRI studies have evaluated white matter volume differences between patients with schizophrenia and controls, and these findings have been largely negative [21, 22] (see also review in [1]). A study by Wible and coworkers [22] , however, reported correlations between white matter volume and temporal lobe volume reduction (i.e. superior temporal gyrus, amygdala-hippocampal complex, and parahippocampal gyrus), suggesting a possible relationship between white and gray matter pathology. Moreover, in one of the few studies reporting white matter volume reduction in schizophrenia, Breier and coworkers [23] noted a similar correlation between prefrontal white matter reduction and amygdalahippocampal complex volume reduction. More recently, studies using VBM analyses have shown white matter abnormalities in both temporal and frontal lobe regions [19] , and bilaterally in the frontal lobe [20] .
Thirteen studies published over the past year on structural white matter abnormalities in schizophrenia have used three different strategies: whole white matter volumes, regional white matter volumes, and VBM. More specifically, two studies have investigated whole white matter volumes, thus providing evidence concerning general processes that may occur in schizophrenia. In contrast, eight studies have investigated regional white matter volume changes, whereby whole white matter is divided into lobar segments. Finally, three studies have used VBM analyses to search for localized, focal changes within the white matter in schizophrenia (see Table 1 ).
Whole white matter
Studies that evaluate whole white matter volumes generally involve automated brain segmentation, which, although not sensitive to local anatomical abnormalities, may be an indicator of the general processes taking place in the white matter (see Fig. 1 for an example of the segmentation). Christensen et al. [25 ] , for example, reported a decrease in total white matter volume in 13 patients diagnosed with schizophrenia, following 4 weeks of successful neuroleptic medication (success defined by a reduction in positive symptom scores). These authors suggested that excitotoxicity-induced myelin swelling causes functional and anatomical disconnectivity (manifesting as psychosis exacerbation), which remits after successful treatment, thus accounting for a reduction in white matter volume.
The notion that clinical symptoms in schizophrenia may be related to an acute inflammatory process is interesting, and has also been suggested in multiple sclerosis and metachromatic leukodystrophy studies, in which inflammation and demyelination are the primary pathological processes observed. Moreover, investigators have been impressed by the similarities observed between patients diagnosed with schizophrenia and patients diagnosed with metachromatic leukodystrophy [37] . The early symptoms observed in this disorder are so similar to schizophrenia that these patients are often misdiagnosed with schizophrenia. The symptoms include delusions, hallucinations, and cognitive disruptions, all hallmark symptoms of schizophrenia. Of further interest here, a demyelinating process in schizophrenia has also been suggested by several postmortem studies (discussed below).
Studying white matter abnormalities in schizophrenia also affords an opportunity to investigate possible demyelination/degenerative processing taking place in the central nervous system, as well as to examine white matter abnormalities in the context of a genetic predisposition to developing schizophrenia. This focus fits in nicely with the notion that schizophrenia is a disorder of neurodegenerative processes or of neurodevelopmental origin, though the two are not mutually exclusive (see review in [1]). Relevant here is the second study to use whole white matter volume measurements, by Hulshoff Pol and coworkers [24] , who evaluated gray and white matter in 11 monozygotic and 11 same-gender dizygotic twins discordant for schizophrenia, in comparison with 11 monozygotic and 11 dizygotic healthy twins. These investigators reported white matter volume reductions in all twins discordant for schizophrenia, while gray matter volumes decreased only in patients. These authors concluded that white matter volume reflects the increased genetic risk to developing schizophrenia, while gray matter volumes are more likely associated with environmental factors.
Region of interest approach to evaluating local white matter
Eight additional papers published last year used a hypothesis-driven region of interest (ROI) approach. This technique can be either manual, which involves manual tracing of small brain regions, semiautomatic, involving manual division of automatically derived white matter maps, or fully automatic, when software is used to detect and segment regions of the brain based on atlas registration.
Mitelman and coworkers [29] used automatically segmented frontal, temporal and occipital white matter regions in patients diagnosed with schizophrenia who had good versus poor outcome, and found that white matter volume in temporal and occipital lobe, but not prefrontal lobe, were associated with poor outcome. Moreover, additional volume loss was observed for patients, compared with controls, regardless of outcome, although white matter volume was decreased primarily in the occipital region. However, in a similar study by Milev et al. [34] , white matter in prefrontal and temporal regions was measured, and no relationship was found between 5year outcome and volumes in any of the brain regions evaluated. Ho and coworkers [32] evaluated the relationship between frontal, temporal, parietal and occipital white matter volumes and duration of untreated psychosis, and they did not find any significant correlations between these two factors. These investigators also reported no relationship between medication and pre-frontal white matter volumes. Moreover, a study by Arango et al. [35] investigated prefrontal white matter before and after a 10-week period of treatment with clonazepine (22 patients) and haloperidol (23 patients), and found no relationship between medication dosage and white matter volume changes. These latter findings are thus not consistent with the aforementioned whole white matter volume changes observed in patients with schizophrenia in response to medical treatment [25 ] . Methodological differences could be one possible explanation for these discrepancies.
Another ROI study this past year [33 ] investigated the relationship between progressive reduction of white matter volume in schizophrenia and clinical symptoms, and demonstrated that negative symptoms were correlated with frontal lobe volume reduction. Mathalon and coworkers [31] focused on degenerative processes of white matter in patients with schizophrenia comorbid for alcoholism, and found, although statistically nonsignificant, additional white matter volume reduction in prefrontal white matter in the comorbid sample.
In addition to the whole white matter study discussed above by Hulschoff Pol et al. [24] , there have been two ROI studies that have investigated evidence for a developmental origin of white matter changes. The first is a study by Bartzokis and colleagues [30 ] who demonstrated an association between white-to-gray matter ratios and age in controls, and the lack thereof in patients with schizophrenia. This finding was interpreted as suggesting that the adult developmental process associated with white matter maturation and myelination is dysregulated in schizophrenia. The second study, by Highley and colleagues [36] , evaluated white matter volume and an index of gyrification in 61 patients with schizophrenia and 42 controls. White matter was divided into frontal, temporal, and parieto-occipital white matter. Findings showed that occipito-parietal white matter volumes decreased in females with schizophrenia and increased in males with schizophrenia, compared with controls, suggesting that the changes in connectivity underlying the pathogenesis of schizophrenia are gender specific and are expressed in occipito-parietal white matter.
Voxel-based morphometry analyses of white matter
Finally, within the last year, three VBM studies have focused on white matter abnormalities in schizophrenia. VBM is a new image analysis technique that has become very popular in recent years. Its popularity is primarily due to the fact that it is an automated procedure that can be used to investigate multiple brain regions at the same time, and is therefore much less time consuming than the traditional ROI approach. Due to its automation, the method is also statistically much more powerful, as very large cohorts can be easily compared.
Using VBM, and then confirmed with manual ROI analyses, Zhou and coworkers [28] reported decreased volume and increased asymmetry of the anterior limb of the internal capsule in 53 patients diagnosed with chronic schizophrenia compared with 48 controls. In a separate study that also used VBM analysis, Hulshoff Pol and coworkers [27 ] reported decreased white matter density within the corpus callosum, right anterior limb of the internal capsule, and anterior commissure in a cohort of 159 patients diagnosed with schizophrenia compared with 158 controls. In addition, Spalletta and coworkers [26] reported white matter density reductions in arcuate fasciculus, uncinate fasciculus, cortico-striatal fibers and fronto-temporal fibers in a cohort of 28 patients diagnosed with chronic schizophrenia, when compared with 28 matched controls.
Summary
MRI structural white matter findings in schizophrenia over the last year are generally in agreement with previous investigations. Multiple brain regions appear to be affected in schizophrenia, although rather than generalized deficits, these abnormalities appear to be localized predominantly in temporal and frontal white matter. We note also the increase in use of new methodological advances, such as VBM, which offer a quick way to evaluate multiple white matter regions across many patients, in contrast to the usual labor-intensive manual tracing of brain regions of interest. As a result of improvements in analysis techniques, white matter changes in schizophrenia are also better anatomically localized, and findings, similar to some DTI studies (reviewed below), point to the likely importance of frontal-temporal connections (i.e. uncinate fasciculus, arcuate fasciculus, internal capsule, cingulum bundle), as well as interhemispheric connections (i.e. corpus callosum, anterior commissure) in the neuropathology of schizophrenia. Additionally, medication effects have been observed over a short period of time (4 weeks), suggesting that myelin inflammatory processes may be going on during psychosis exacerbation. Finally, another interesting observation comes from work published this past year by Bartzokis and coworkers [30 ] , who documented differences in the maturation of white matter processes (myelination) between patients diagnosed with schizophrenia and normal controls, which could underlie a predisposed vulnerability for some individuals to develop schizophrenia [38] . Only more careful, longitudinal studies of schizophrenia, however, will be able to address the question of white matter changes over time.
Diffusion tensor imaging studies in schizophrenia DTI has been increasingly popular since its introduction in 1994 [39] . This magnetic resonance in-vivo technique is based on detecting the motion of water molecules in the presence of directionally oriented magnetic gradients. Figure 2 shows an example of DTI. This imaging technique thus makes it possible to detect the direction and orientation of water diffusion in the brain, and is shown to be sensitive to detecting white matter fiber tract abnormalities in various brain pathologies, including brain tumors, ischemia, multiple sclerosis, alcoholism, Alzheimer's disease, and so on (for a review, see [13, 14 ] ). Fractional anisotropy, a quantitative index of white matter coherence and integrity, is the most frequently used measure to evaluate water diffusion in white matter. Schizophrenia studies, thus far, have demonstrated abnormalities in multiple white matter regions, including the corpus callosum [40, 41] , the uncinate fasciculus [42] , prefrontal and temporal white matter [43, 44] , as well as abnormalities in the internal capsule [43] .
This year alone, 11 additional studies have used DTI to investigate white matter abnormalities in schizophrenia ( Table 2 ). The popularity of DTI is understandable, since this technique affords the unique opportunity to visualize and to quantify white matter fiber bundles, something not possible even a decade ago. Studies published in the last year have evaluated white matter fiber tracts, namely superior and middle cerebellar peduncles [45] , cingulate bundle [46] , uncinate fasciculus [47 ] , arcuate fasciculus [47 ] , and corpus callosum [46, 48] . In addition, nonspecific, larger areas of prefrontal, occipital, temporal and parietal white matter have also been studied [45, 46, 49] . Finally, VBM analyses, an increasingly popular method to analyze whole white matter without a priori hypothesis, have been applied to maps of fractional anisotropy in patients with schizophrenia and in controls [47 ,50,51 ,52 ] . DTI has also been used to look at white matter asymmetry in schizophrenia, an important issue, particularly in light of the emphasis placed on neurodevelopmental abnormalities in schizophrenia.
More specifically, cerebellar connections have been evaluated in two studies in schizophrenia published last year, with conflicting results. Okugawa and colleagues [55] reported middle cerebellar peduncle abnormalities in a group of 25 patients with schizophrenia, when compared with 21 healthy controls (along with its relationship to the dosage of medication). However, Wang and colleagues [45] evaluated 29 patients with schizophrenia and 20 controls, and reported no differences in either middle, or superior cerebellar peduncles. Different resolution, as well as different planes used (axial versus sagittal), may account for these differences. Two additional ROI studies found no differences in the corpus callosum in patients with schizophrenia compared with controls [46, 48] (so far the most consistent finding in DTI schizophrenia research), while one study did [50] , and one study did not find differences between groups for the internal capsule [46] . Two studies found abnormalities in the cingulum bundle [14 ,46] .
Prefrontal, temporal, parietal and occipital white matter regions have been parcellated and evaluated in two separate studies [46, 53 ] , and while one study reported group differences in all these regions [53 ] , the other reported no differences in any of these regions [46] . In addition, one study [49] investigated white matter within the prefrontal cortex in schizophrenia (no control group was included), and found correlations between decreased fractional anisotropy and increased negative symptoms.
VBM analyses have also been applied to diffusion tenor images and used to compare patients diagnosed with schizophrenia with controls. There have been three such studies over the last year. The first is a study by Burns and coworkers [47 ] who reported decreased fractional anisotropy in uncinate fasciculus, arcuate fasciculus, but not in cingulate fasciculus in patients with schizophrenia compared with controls. The second study by Ardekani and coworkers [50] reported a reduction of fractional anisotropy in patients with schizophrenia in the corpus callosum, as well as in frontal, parietal, occipital and temporal white matter. Finally, the third study by Hubl and coworkers [51 ] reported fractional anisotropy reduction in schizophrenia in the uncinate fasciculus, arcuate fasciculus, inferior longitudinal fasciculus, and in the corpus callosum.
Of further note, when patients with schizophrenia are divided into those with and those without auditory 
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hallucinations, patients with auditory hallucinations have higher fractional anisotropy in the arcuate fasciculus, cingulum bundle and in the corpus callosum compared with patients without auditory hallucinations [51 ] . Also those patients with hallucinations, when compared with controls, had higher fractional anisotropy values in the arcuate fasciculus and corpus callosum. This is thus far the only study that has shown an increase in diffusion anisotropy in schizophrenia. The authors speculated that an increase in fractional anisotropy in the arcuate fasciculus may be associated with an overactivation of regions associated with language in patients with hallucinations.
Another very interesting study published over the last year [52 ] is a study published by our laboratory that evaluated the asymmetry of white matter fiber tracts in schizophrenia patients compared with controls. This study also used VBM analyses, although unlike other studies it utilized a high-order co-registration method that registers brains to the template on the basis of directional information extracted from diffusion images, and thus is more precise in registration than the traditional VBM methods. This study reported asymmetry in controls in the corpus callosum, cingulate bundle, optic radiation, superior cerebellar peduncle, the anterior limb of the internal capsule, the uncinate fasciculus, and in the superior longitudinal fasciculus. This asymmetry was either decreased or diminished in schizophrenia patients. The authors suggested that their findings support a neurodevelopmental origin for schizophrenia.
Summary DTI findings in schizophrenia over the last year provide further evidence for white matter abnormalities in schizophrenia. The results, however, are often conflicting. While some studies published this year confirm previous findings, some contradict them. One possible reason for the discrepancies reported in DTI studies may be that the resolution of today's diffusion scans is low, compared with structural MRI, and the noise is high. Another possible reason is that unlike the structural MRI research, where ROI analysis is the gold standard, and every new method can be tested against this gold standard, in DTI research at this time there is no such standard. Finally, another possible reason for inconsistent findings is the significant methodological differences among DTI studies. Further research is needed to address these issues, including the development of better acquisition sequences so as to increase resolution, and better post-processing tools, in order to take full advantage of the diffusion phenomenon.
Other magnetic resonance imaging studies in schizophrenia
Another MR technique that is sensitive to axonal and myelin density, and enables the detection of abnormalities in white matter structure, is magnetization transfer imaging. This imaging technique provides an index of axonal/myelin density, called magnetization transfer ratio (MTR) (see an example in Fig. 3 ). This method has been used previously in two publications [15, 56] in which gray matter, but not white matter changes in schizophrenia patients were observed. This year, however, Bagary and coworkers [17] used MTR to evaluate patients with schizophrenia and controls and showed that the uncinate fasciculus axonal density/myelin density in schizophrenia is smaller than that observed in controls. This finding is consistent with two diffusion studies in schizophrenia discussed above [42, 47 ] , and further suggests a disruption of anatomical connectivity between the frontal and temporal lobes, as this fiber connects temporal pole and orbital frontal cortex.
Finally, this past year, T2 relaxation analysis, sensitive to the fraction of water bonded to myelin, was applied to schizophrenia in order to investigate white matter myelin abnormalities in both first episode and chronic samples [57 ] . Interestingly, the results of the Flynn et al. study also confirm the results of the Ho et al. [33 ] structural study discussed above, which showed that in controls, but not in patients with schizophrenia, both myelin water fraction in whole white matter, as well as in prefrontal white matter, increased with age, thus demonstrating ongoing maturation/myelination, at least in controls.
Summary
MTR and T2 relaxation analysis provide evidence for white matter abnormalities in schizophrenia, thereby confirming some of the structural and DTI findings published in recent years. Neither of these two methods have been used frequently, although both show great potential, and both fully complement other methods, such as structural MRI and DTI, for investigating white matter abnormalities in schizophrenia, as well as for increasing the specificity of these findings.
Histopathological studies in schizophrenia
Until recently, there were only a small number of postmortem studies of white matter in schizophrenia, and these findings, similar to the MRI findings, were inconclusive. Specifically, two earlier studies reported decreased fiber number and density in the anterior commissure and the corpus callosum in women but not in men with schizophrenia [58, 59] , and no differences in the number and density of fibers in the uncinate fasciculus [60] .
Of further note, there is growing evidence to suggest that glial cells, particularly oligodendrocytes, are abnormal in schizophrenia [11, 12] . The Uranova et al. [11] study reported an abnormal expression of myelin-related genes in schizophrenia. The Hakak et al. [12] study, using electron microscopy, showed both qualitative and quantitative abnormalities in postmortem brains of patients with schizophrenia in the oligodendroglia in the prefrontal cortex and caudate nucleus, including a marked increase in the density of concentric lamellar bodies (indicating damage to myelinated fibers) in the caudate nucleus of schizophrenic brains. Importantly, if glial dysfunction is confirmed in schizophrenia, this alone could explain abnormal neuronal cytoarchitecture and functional deficits including fronto-temporal disconnections observed in schizophrenia (see also the recent review of white matter findings in schizophrenia by Davis et al. [61] ).
As attention shifts gradually from gray to white matter pathology in schizophrenia, and since fronto-temporal abnormalities are among the most compelling findings in this disorder, it is not surprising that this year alone, nine new schizophrenia studies investigated frontal and temporal white matter in postmortem brains of patients with schizophrenia (see Table 3 ).
From the nine studies published last year that focused on white matter pathology, five investigated oligodendrocyte number, density, function, and distribution, three evaluated the distribution of neurons in white matter (interstitial cells), and one evaluated the length of fibers in whole white matter, as well as in the prefrontal cortex.
Oligodendrocyte number, density, distribution and function
With respect to the five studies investigating oligodendrocyte number, density, distribution, and function, this work followed earlier work by Uranova and colleagues [11] , who found a reduction in number and size of oligodendrocytes in prefrontal and thalamic areas in schizophrenia. This past year, the same researchers evaluated oligodendrocyte density in layer VI of Brodmann area 9 of the prefrontal cortex and in adjacent white matter in schizophrenia [65] . The investigators found a significant decrease in numerical density of oligodendrocyte cells in gray, but not white matter in schizophrenia.
Another study by Hof and coworkers [66 ] , which investigated oligodendrocyte density and spatial distribution in layer III of Brodmann area 9 and gyral white matter in schizophrenia, found decreased oligodendrocyte number and density in both gray and white matter in patients with schizophrenia. The patients in this sample were, however, much older than in the Uranova et al. study (mean 77 versus 45 in Uranova study), which could account for the observed differences.
Flynn and co-authors [57 ] investigated oligodendrocyte function in the anterior frontal cortex in schizophrenia. They measured two oligodendrocyte-associated proteins -cyclic nucleotide phosphodiesterase (CNP-ase), and myelin-associated glycoprotein (MAG). The results showed a decrease in immunoreactivity in both proteins in schizophrenia, compared with controls. Interestingly, these two proteins have also been described in a study by Hakak and coworkers [12] , who reported lower levels of mRNA for genes related to these proteins. Finally, the two remaining studies that investigated oligodendrocyte function in schizophrenia focused on their relevance to a neurodevelopmental hypothesis. The first of these is a study by Tkachev et al. [67 ] who evaluated the expression of oligodendrocyte and myelin-related genes in prefrontal cortex (mixture of gray and white matter) in schizophrenia. Here, a microarray analysis of RNA in schizophrenia revealed decreased expression of genes related to oligodendrocyte lineage (basic loop helix protein, OLIG2; high mobility group protein, SOX10), oligodendrocyte growth and differentiation (neuregulin receptor, ERBB3; transferin), and mature myelinating oligodendrocyte function (MAG; proteolipid protein 1, PLP1; myelin protein zero, MPZL1; oligodendrocytespecific protein, CLDN11; myelin oligodendrocyte protein, MOG) in schizophrenia.
The second of these studies was conducted by Aston et al. [68] , and evaluated the expression of genes related to oligodendrocyte function, again using microarray RNA analysis, but this time in middle temporal gyrus in 130 Schizophrenia schizophrenia. Results from this study also showed a significant decrease in the expression of myelinationrelated genes, namely MAG, plasmolipin (PLLP), PLP1, ERBB3. In addition, these investigators also reported a decreased expression of genes regulating neurodevelopment (i.e. tumor necrosis factor receptorassociated factor 4, TRAF4; basic helix-loop-helix protein, Neurodi; histonedeacetylase 3).
The distribution of neurons in white matter
The remaining three studies published last year focused on interstitial neurons, neurons of unclear function that can be found in small quantities in white matter. The abnormal distribution of interstitial white matter neurons (IWMNs) in schizophrenia is thought to provide support for the neurodevelopmental hypothesis of schizophrenia. It has been previously found that these neurons, representing remnants of the cortical subplate, and involved in cortical development and in the guidance of neuronal migration, are abnormally distributed in schizophrenia. Studies published previously, for example, have found increased density of interstitial neurons in prefrontal, temporal [70, 71] and parietal lobe [72] white matter. This year, Eastwood and Harrison [62 ] documented increased density of IWMNs in superficial temporal white matter, which was not observed in deep white matter. In addition, the expression of reelin, a key developmental signaling molecule, was reported to be decreased in both superficial as well as deep white matter IWMNs in schizophrenia. Since interstitial neurons play a role in brain development, specifically in neuronal migration, thus indirectly involved in forming connections between brain regions, investigators interpreted their findings as supportive of neurodevelopmental theories of schizophrenia. In addition, since reelin is viewed as the key developmental signaling molecule, the observed relationship between density of interstitial neurons and reelin expression may contribute to the aberrant synaptic connectivity observed in schizophrenia.
Kirkpatrick and coworkers [63] also investigated IWMNs in schizophrenia, evaluating both deficit and nondeficit patients with schizophrenia. They found increased density of IWMNs in dorsolateral prefrontal cortex in the deficit group (n ¼ 3) compared with the nondeficit (n ¼ 4) as well as the control (n ¼ 5) groups, suggestive of different pathophysiology for deficit and nondeficit schizophrenia (however, the deficit group was much older, which could also account for the differences). Finally, Rioux et al. [64] , using the same staining method as Kirkpatrick (see Table 3 for methodological details), also found a maldistribution of IWMNs, especially in the deeper white matter of the parahippocampal gyrus in patients with schizophrenia compared with controls.
While abnormal density and function of oligodendrocytes, and maldistribution of interstitial white matter neurons in schizophrenia may suggest the involvement of white matter connections in the neuropathology of schizophrenia, the fibers interconnecting different brain regions have never been quantified in schizophrenia. The first study to evaluate interconnecting brain regions was conducted this year by Marner and Pakkenberg [69 ] . A stereological method was used to quantify the length of myelinated nerve fibers in the whole brain, as well as in the prefrontal cortex, and no group differences were found.
Summary
Postmortem white matter findings in schizophrenia published over the last year, similar to other methods discussed, are in agreement with previous investigations. Oligodendrocyte function, as well as their density and distribution, seem to be affected in schizophrenia. The same can be said of the density and distribution of interstitial neurons located in white matter. While these factors can contribute to decreased connectivity and disconnection syndromes observed in this disorder, the organization and thickness of the fibers, rather than their number, seem to be affected.
Future directions for the investigation of white matter abnormalities in schizophrenia
With the advent of technological advances in both invitro postmortem as well as in-vivo MRI methods, we are just beginning to understand more fully the role that white matter pathology plays in schizophrenia. Hypotheses regarding connectivity abnormalities in schizophrenia can now be approached empirically, as for example the evaluation of fronto-temporal connections such as the uncinate fasciculus, cingulum bundle, arcuate fasciculus, fornix, and so on. Not surprisingly, with new methods being developed almost every year, interest in white matter abnormalities in schizophrenia has grown exponentially. Some of these methods use already established techniques, and show consistent results (such as postmortem findings of oligodendrocyte and interstitial neuron function and density), while other methods are still in the developmental phase (such as genetic and diffusion methods).
What is clear, however, is that future schizophrenia studies investigating white matter abnormalities will need to combine multiple imaging techniques that highlight white matter pathologies, such as DTI, proton spectroscopy, magnetization transfer techniques and relaxation time measurements, with postmortem studies in order to both define microscopic pathologies observed in schizophrenia as well as to validate in-vivo methods. It is also important to understand further the relationship between MRI-derived measures and the organization of axons and myelin in white matter. In addition, closer examination of the relationship between age, gender, and medication, as well as other confounding variables, and white matter pathology, would enable us to understand more fully white matter changes in schizophrenia. Of note, improvements in MRI methodology will be needed to achieve more reproducible results in schizophrenia. Also, there are several new and exciting in-vivo technologies on the horizon, such as fiber tractography, where long fiber bundles can be followed from one part of the brain to another, which will likely also increase our understanding of the processes going on in white matter that affect brain connectivity and underlie schizophrenia symptoms (Fig. 4) . Finally, such studies should be conducted in concert with functional MRI and positron emission tomography imaging in order to characterize and to understand more fully both functional and structural abnormalities in schizophrenia. An example of fiber tractography of the uncinate fasciculus, co-registered with a DTI fractional anisotropy coronal image, is displayed in Fig. 5 , in which the neuroanatomical connections provided by the fiber tractography can be appreciated.
Conclusion
Schizophrenia is no longer viewed as a disorder characterized by gray matter abnormalities alone. Recent studies, reviewed here, provide strong evidence for a disruption of white matter integrity in schizophrenia. For example, the aging process, which involves white matter myelination/maturation, may be quite different in patients with schizophrenia compared with controls. Moreover, the distribution of white matter cells (oligodendrocytes and interstitial neurons) may also be abnormal in schizophrenia. These latter findings are supported by recent genetic studies, which provide evidence for abnormalities in myelin formation. Future studies need to follow up these intriguing findings as well as to develop further white matter tractography methods, based on DTI and MTR, that will likely aid in our ability to quantify specific white matter fiber connections that are disrupted in schizophrenia. More studies are also needed that highlight the role of white matter abnormalities in schizophrenia in the context of gray matter abnormalities and functional, clinical, and behavioral abnormalities, using functional and structural imaging as well as cognitive and behavioral probes.
